ADVOCATE aims for continuous support systems, evaluated with the FDA and an independent body.
The U.S. agency ARPA-H selects teams from the ADVOCATE program, which seeks to build an agentic clinical AI to accompany patients with heart failure.
The programme provides for independent evaluation and collaboration with the FDA, which is essential for a tool to intervene between two consultations.
Read the full article on the original source
Go to the source →